drugset / Trial / NCT01152814

Study to Evaluate Safety and Immunogenicity of Sub-unit Adjuvanted Influenza Vaccine Administered to Elderly Subjects, Formulation 2010-2011

NCT01152814

Phase 2 Completed 64 enrolled Novartis Vaccines
NaSingle-groupOpen-labelPrevention

Summary

This study will evaluate the safety and immunogenicity of a sub-unit, adjuvanted influenza vaccine administered to elderly subjects

Timeline

Start
2010-06
Primary completion
2010-06
Completion
2010-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Quadrivalent influenza vaccine Vaccine Intramuscular

Indications